19 Jan 2017

Share issuance in settlement of bond repayment for QT Vascular Ltd

Danny Lim and Caitlin Huang are advising QT Vascular Ltd. (listed on the Catalist Board of the SGX-ST) in the settlement of its first tranche due amount of US$5.475 million in respect of its 8% convertible bonds via the issuance of new shares in the company amounting to approximately 11.3% of its existing share capital.

QT Vascular is engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases. It collaborates with industry specialists and physicians who are key opinion leaders to develop and offer physicians and patients new and differentiated devices to improve outcomes in complex peripheral and coronary interventions